12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Company News  |  Deals

Gencia, Myelin Repair Foundation deal

Gencia and the foundation partnered to evaluate the myelin regenerating capabilities of Gencia's preclinical compounds for multiple sclerosis (MS) using the research tools and assays at the...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >